drugset / Trial / NCT00399204
Comparison of Cardiovascular Outcomes of Pioglitazone and Metformin in Type 2 Diabetes Patients
Phase 4
Withdrawn
Post Graduate Institute of Medical Education and Research, Chandigarh
Council of Scientific and Industrial Research, India · collab
RandomizedParallel-groupOpen-labelHealth-services research
Summary
The study aims to see if there is any significant difference in the cardiovascular outcomes in type 2 diabetes patients who are treated with pioglitazone or Metformin
Timeline
- Start
- 2006-01
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | — | — |
| Subject | Pioglitazone | Small molecule | — | — |